Interleukin 11 therapy causes acute left ventricular dysfunction.
Saved in:
| Title: | Interleukin 11 therapy causes acute left ventricular dysfunction. |
|---|---|
| Authors: | Sweeney M; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., O'Fee K; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Villanueva-Hayes C; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Rahman E; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Lee M; National Heart and Lung Institute, Imperial College London, London W12 0NN, UK., Tam CN; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK., Pascual-Navarro E; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Maatz H; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13092 Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany., Lindberg EL; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13092 Berlin, Germany., Vanezis K; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK.; National Heart and Lung Institute, Imperial College London, London W12 0NN, UK., Ramachandra CJ; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore., Andrew I; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Jennings ER; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Lim WW; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore., Widjaja AA; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore., Carling D; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Hausenloy DJ; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.; The Hatter Cardiovascular Institute, University College London, London WC1E 6HX, UK., Hübner N; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13092 Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.; Charite, Universitätsmedizin Berlin, 10117 Berlin, Germany., Barton PJR; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK.; National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.; Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London SW3 6NP, UK., Cook SA; MRC-Laboratory of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK.; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore. |
| Source: | Cardiovascular research [Cardiovasc Res] 2024 Dec 31; Vol. 120 (17), pp. 2220-2235. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
